LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Home‐based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic‐based treatment in patients with stable disease: A retrospective study of 40 patients

Photo by atikahakhtar from unsplash

context of appropriate and essential medical care, the treatment of AA satisfies the definition of medical necessity and is merited, by objective measures, in the same way that treatment of… Click to show full abstract

context of appropriate and essential medical care, the treatment of AA satisfies the definition of medical necessity and is merited, by objective measures, in the same way that treatment of other chronic dermatoses, such as atopic dermatitis and psoriasis, is merited. Lastly, Skindex-16 is not specific to AA and might not be the ideal instrument for assessing patient satisfaction with treatment. Assessment with AA-specific instruments, such as the AA Quality-ofLife Index, might be more appropriate. Because patient-reported outcomes are becoming increasingly important in clinical trials, instruments that effectively assess the psychosocial impact of AA are necessary.

Keywords: contact immunotherapy; diphenylcyclopropenone alopecia; home based; treatment; based contact; immunotherapy diphenylcyclopropenone

Journal Title: Journal of the American Academy of Dermatology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.